| Title : Effect of vasoactive intestinal polypeptide on the release of serotonin from the in vitro vascularly perfused small intestine of guinea pig - Schworer_1989_Naunyn.Schmiedebergs.Arch.Pharmacol_339_540 |
| Author(s) : Schworer H , Racke K , Kilbinger H |
| Ref : Naunyn Schmiedebergs Arch Pharmacol , 339 :540 , 1989 |
|
Abstract :
Isolated segments of the guinea pig small intestine were vascularly perfused and the release of endogenous serotonin (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) into the portal vein was measured. All test substances were intraarterially perfused. Vasoactive intestinal polypeptide (VIP, 1 pmol/l-100 nmol/l) inhibited the spontaneous release of 5-HT and 5-HIAA. The maximal inhibitory effect (about 60%) was seen at 100 pmol/l. The effect of VIP on the spontaneous release of 5-HT and 5-HIAA was not changed in the presence of 1 mumol/l tetrodotoxin (TTX). Raising intraluminal pressure by 500 Pa for 5 min increased the release of 5-HT and 5-HIAA by about 25%. Raising the intraluminal pressure in the presence of VIP reduced the release of 5-HT and 5-HIAA by about 75%. In the presence of TTX (1 mumol/l), raising intraluminal pressure also caused a decrease of the release of 5-HT and 5-HIAA which was unaffected by the additional presence of VIP. The fluid volume expelled during peristaltic activity was not affected by VIP, but reduced by about 90% in the presence of TTX. In conclusion the results demonstrate a direct inhibitory effect of VIP on the release of 5-HT from the enterochromaffin cells. In addition, VIP appears to interfere with the neuronally mediated stimulation of 5-HT release during peristaltic activity. |
| PubMedSearch : Schworer_1989_Naunyn.Schmiedebergs.Arch.Pharmacol_339_540 |
| PubMedID: 2475786 |
Schworer H, Racke K, Kilbinger H (1989)
Effect of vasoactive intestinal polypeptide on the release of serotonin from the in vitro vascularly perfused small intestine of guinea pig
Naunyn Schmiedebergs Arch Pharmacol
339 :540
Schworer H, Racke K, Kilbinger H (1989)
Naunyn Schmiedebergs Arch Pharmacol
339 :540